Dasatinib population pharmacokinetics in patients with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (ph plus all)

被引：0

作者：

Dai, Guowei ^{[1
]}

Roy, Amit ^{[1
]}

Mandava, Mohan ^{[1
]}

Blackwood-Chirchir, Anne ^{[1
]}

Luo, Roger ^{[1
]}

Wu, Chiyuan ^{[1
]}

Pfister, Marc ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Princeton, NJ 08543 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 46卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

100

引用

页码：1085 / 1085

页数：1

共 50 条

[41] The OMNI Patient Registry: A Prospective, Observational, Non-Interventional Registry to Evaluate Vascular Safety of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) [J].

Stemhagen, Annette ;

Adib, Deyaa ;

Lustgarten, Stephanie ;

McGarry, Lisa ;

du Moulin, Ruth ;

Santillana, Sergio .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 :S309-S310

[42] A phase II study of dasatinib in patients with chronic myeloid leukemia (CML) in lymphoid blast crisis or Philadelphia-Chromosome positive acute lymphoblastic leukemia (Ph plus ALL) who are resistant or intolerant to imatinib: The 'START-L' CA180015 study. [J].

Ottmann, OG ;

Martinelli, G ;

Dombret, H ;

Kantarjian, H ;

Hochhaus, A ;

Simonsson, B ;

Aloe, A ;

Apanovitch, A ;

Shah, N .

BLOOD, 2005, 106 (11) :17A-17A

[43] Emergence of Philadelphia positive chronic myeloid leukemia in a patient with Philadelphia negative acute lymphoblastic leukemia [J].

Demirkan, F ;

Öztop, I ;

Özsan, H ;

Ündar, B .

LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) :251-252

[44] A Phase II Study of the Combination of Decitabine, Venetoclax and Ponatinib in Patients with Chronic Myeloid Leukemia (CML) in Myeloid Blast Phase (MBP) or Philadelphia-Chromosome Positive (Ph plus ) Acute Myeloid Leukemia (AML) [J].

Senapati, Jayastu ;

Ravandi, Farhad ;

DiNardo, Courtney D. ;

Issa, Ghayas C. ;

Sasaki, Koji ;

Konopleva, Marina ;

Pemmaraju, Naveen ;

Chien, Kelly S. ;

Ohanian, Maro ;

Jabbour, Elias ;

Maiti, Abhishek ;

Roy, Edith ;

Delumpa, Ricardo ;

Rivera, Juan ;

Loiselle, Christopher ;

Banks, Glenda ;

Kantarjian, Hagop ;

Short, Nicholas .

BLOOD, 2022, 140 :3880-3882

[45] Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia [J].

Luskin, Marlise R. ;

Murakami, Mark A. ;

Keating, Julia ;

Flamand, Yael ;

Winer, Eric S. ;

Garcia, Jacqueline S. ;

Stahl, Maximilian ;

Stone, Richard M. ;

Wadleigh, Martha ;

Jaeckle, Stella L. ;

Hagopian, Ella ;

Weinstock, David M. ;

Liegel, Jessica ;

Mcmasters, Malgorzata ;

Wang, Eunice S. ;

Stock, Wendy ;

Deangelo, Daniel J. .

BLOOD, 2025, 145 (06) :577-589

[46] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) [J].

Samra, Bachar ;

Kantarjian, Hagop M. ;

Sasaki, Koji ;

Konopleva, Marina Y. ;

Khouri, Rita ;

O'Brien, Susan M. ;

Ferrajoli, Alessandra ;

Nunez, Cesar ;

Kadia, Tapan M. ;

Jabbour, Elias .

BLOOD, 2019, 134

[47] Maxizyme, a novel ribozyme, induces cell death of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph plus ALL). [J].

Soda, Y ;

Tani, K ;

Bai, YS ;

Chen, MH ;

Izawa, K ;

Saiki, M ;

Kuwabara, T ;

Warashina, M ;

Tanabe, T ;

Miyoshi, H ;

Sugita, K ;

Nakazawa, S ;

Tojo, A ;

Taira, K ;

Asano, S .

BLOOD, 2002, 100 (11) :656A-656A

[48] PHILADELPHIA-CHROMOSOME (PH1) POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) [J].

PRIEST, JR ;

WARKENTIN, PI ;

LEBIEN, TW ;

LINDQUIST, LL ;

BRUNNING, RD ;

YASMINEH, WG ;

KERSEY, JH ;

NESBIT, ME ;

COCCIA, PF .

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR) :331-331

[49] Discovery of a Selective PROTAC Degrading Untamable BCR::ABL1 Compound Mutants in Chronic Myelogenous Leukemia (CML)and Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) [J].

Rouhimoghadam, Milad ;

Tang, Hua ;

Bates, Briana ;

Liao, Junzhuo ;

Uribe-Cano, Daniela ;

Tang, Weiping ;

Deininger, Michael .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S336-S336

[50] Efficacy of Combination Blinatumomab and Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) and Chronic Myeloid Leukemia in Lymphoid Blast Phase (CMLBP) in a Real World Setting [J].

Tobon, Katherine ;

Consalvo, Kylie ;

Kareem, Syeda Saba ;

Lancet, Jeffrey E. ;

Komrokji, Rami S. ;

Pinilla-Ibarz, Javier ;

Sallman, David ;

Eatrides, Jennifer ;

Walker, Alison R. ;

Chavez, Julio C. ;

Isenalumhe, Leidy Lismeris ;

Shah, Bijal .

BLOOD, 2024, 144 :2821-2821

← 1 2 3 4 5 →